Motofen Tablet
NDC Package 83107-011-10
Package Information
Motofen (difenoxin and atropine sulfate) tablets is a medication used to treat diarrhea. This formulation utilizes a tablet delivery system. Marketed by Legacy Pharma Usa Inc., this product is identified by NDC 83107-011 and is authorized under FDA application NDA017744.
Identification & Billing
- RxCUI: 1190738 - difenoxin 1 MG / atropine sulfate 0.025 MG Oral Tablet
- RxCUI: 1190738 - atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet
- RxCUI: 1190740 - Motofen 1 MG / 0.025 MG Oral Tablet
- RxCUI: 1190740 - atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet [Motofen]
- RxCUI: 1190740 - Motofen (atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG) Oral Tablet
Clinical Specifications
- Anticholinergic - [EPC] (Established Pharmacologic Class)
- Antidiarrheal - [EPC] (Established Pharmacologic Class)
- Cholinergic Antagonists - [MoA] (Mechanism of Action)
- Cholinergic Muscarinic Antagonist - [EPC] (Established Pharmacologic Class)
- Cholinergic Muscarinic Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 83107 - Legacy Pharma Usa Inc.
- 83107-011 - Motofen
- 83107-011-10 - 100 TABLET in 1 BOTTLE
- 83107-011 - Motofen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83107-011-10 identifies a specific commercial package of 100 tablet in 1 bottle of Motofen, a human prescription drug labeled by Legacy Pharma Usa Inc.. This tablet is formulated for oral use and contains atropine sulfate; difenoxin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Legacy Pharma Usa Inc. on January 01, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat diarrhea. It helps to decrease the number and frequency of bowel movements. It works by slowing the movement of the intestines. Difenoxin is similar to opioid pain relievers, but it acts mainly to slow the gut. Atropine belongs to a class of drugs known as anticholinergics, which help to dry up body fluids and also slow gut movement.
How is this Legacy Pharma Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83107001110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.